CNBC Investing Club

Investing Club: We're capitalizing on one of our drug stocks' incredible run, selling some shares

Traders work on the floor of the New York Stock Exchange.

We're selling 200 shares of Abbvie (ABBV) at roughly $147.65. Following the trade, we'll own 700 shares of ABBV, decreasing its weighting to 2.68% from 3.42%.